Angelini Farmacéutica takes 24 th place in the ranking of the most respected and recognised pharmaceutical companies in Spain.
Caring for Mental Health in a Digital World. Digital goes live at Angelini Pharma. The first Psychiatry Innovation Summit, organized by Angelini, took place on 4-6 December 2019 in
Angelini Pharma’s international Public Affairs
initiative “Headway2020 : A new roadmap in Mental Health” goes public ahead of the 27th
World Mental Health Day at the European Parliament.
With healthcare policies, medical guidelines and not surprisingly prescriptions increasingly under scrutiny from both Health Authorities and budget holders, the goals for healthcare professional communications are rapidly changing.
The acquired products include BoxaGrippal® (ibuprofen/pseudoephedrine) and Heumann, a herbal medicinal group of teas.
Angelini supports Italian Red Cross providing
medicines to people in Venezuela whose lives have been shattered by violence and
On May 17 Angelini Pharma signed a deal with EUSA
Pharma to be the exclusive distributor of Fotivda (Tivozanib), a product indicated for
the first line treatment of adult patients with advanced renal cell carcinoma (RCC).
The Board of Directors of Angelini Holding
S.p.A., is pleased to announce that Pierluigi Antonelli has been appointed as the new
CEO of Angelini Pharma, effective March 4th, 2019.